Form 4 holding
Director
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 96,219
- Estimated value
- $616,763
- Report date
- 13 Mar 2026
- Price
- $6.41
- Ownership
- as custodian
Michael Singer - Director at Cartesian Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- RNAC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael Singer since 08 Aug 2025
Reported holdings for Michael Singer in Cartesian Therapeutics, Inc.
Form 4 holding
Director
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 49,578
- Estimated value
- $317,794
- Report date
- 13 Mar 2026
- Price
- $6.41
- Ownership
- Direct
Form 4 holding
Director
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 14,788
- Estimated value
- $94,791
- Report date
- 13 Mar 2026
- Price
- $6.41
- Ownership
- by spouse
Form 4 holding
Director
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 7,127
- Estimated value
- $45,684
- Report date
- 13 Mar 2026
- Price
- $6.41
- Ownership
- by trust
Form 4 holding
Director
Cartesian Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 7,800
- Estimated value
- $6,162
- Report date
- 02 Jan 2026
- Price
- $0.7900
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,600
Transaction history for Michael Singer in Cartesian Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.